A detailed history of Aviso Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Aviso Wealth Management holds 10,656 shares of ABBV stock, worth $2.14 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
10,656
Previous 11,225 5.07%
Holding current value
$2.14 Million
Previous $1.93 Billion 9.3%
% of portfolio
1.14%
Previous 1.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $93,224 - $113,418
-569 Reduced 5.07%
10,656 $2.1 Billion
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $232,030 - $270,959
-1,499 Reduced 11.78%
11,225 $1.93 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $153,746 - $175,180
962 Added 8.18%
12,724 $2.32 Billion
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $1.62 Million - $1.82 Million
11,762 New
11,762 $1.82 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aviso Wealth Management Portfolio

Follow Aviso Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aviso Wealth Management with notifications on news.